Applied BioMath, an expert in applying systems pharmacology and mechanistic modeling, simulation and analysis to de-risk drug research and development, has formed a collaboration with Xilio Therapeutics.   “We previously collaborated with Applied BioMath to develop our in vitro and in vivo systems math models,” said Jennifer O’Neil, vice president, translational oncology at Xilio Therapeutics. “We look forward to extending this collaboration to utilizing these systems pha...